Trials / Sponsors / SynerGene Therapeutics, Inc.
SynerGene Therapeutics, Inc.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | SGT-53 in Children With Recurrent or Progressive CNS Malignancies Childhood CNS Tumor | EARLY_Phase 1 | 2022-06-01 |
| Active Not Recruiting | Study of Combined SGT-53 Plus Gemcitabine/Nab-Paclitaxel for Metastatic Pancreatic Cancer Metastatic Pancreatic Cancer | Phase 2 | 2015-01-01 |
| Terminated | Phase II Study of Combined Temozolomide and SGT-53 for Treatment of Recurrent Glioblastoma RECURRENT GLIOBLASTOMA | Phase 2 | 2014-12-01 |
| Suspended | A Study of SGT-53 in Children With Refractory or Recurrent Solid Tumors Neoplasm | Phase 1 | 2014-12-01 |
| Completed | A Phase I Study of Systemic Gene Therapy With SGT-94 in Patients With Solid Tumors Neoplasm | Phase 1 | 2012-01-01 |
| Completed | Safety Study of Infusion of SGT-53 to Treat Solid Tumors Neoplasm | Phase 1 | 2008-02-01 |